Global schizophrenia drugs market is expected to register a CAGR of around 4% over the period of 2021-2027. The schizophrenia drugs market is anticipated to grow on account of the increase in the prevalence of schizophrenia, and the rising demand for improved medication and treatment is expected to drive the market. For instance, In the U.S. alone, the disorder affects approximately 3.5 million...